Now that government regulations have
both increased US prescription drug coverage rates to more than 93% and placed price caps on certain medications, it’s time to focus on other aspects of the healthcare system that adversely impact patients.
FSIC Focus: Continuing the Fight in Healthcare Access
Getting the healthcare you need can be expensive in this country, hurting Americans every single day. That’s why we at the New Jersey chapter of the Financial Services Innovation Coalition (FSIC) have been fighting tooth and nail to bring down those prices. We are fighting this fight in the name of healthcare inclusion and access, and it’s worth celebrating victories when we get them.
“More than 93% of Americans have insurance for prescription drugs”
This means more New Jerseans can afford the life-saving and
life-improving medications they need.
Where do we go from here?
FSIC New Jersey is coming to the table and doing the hard work with our partners to find ways to bring all healthcare prices down while encouraging research & development, innovation, and domestic supply chains.
But drug prices aren’t the only issue we face that increases the cost of health care. We must keep working with hospitals and insurance companies to let them know that the status quo isn’t acceptable. The solutions are clear, we must make progress on:
Taking action on these two issues alone could have an immediate impact on improving outcomes for patients and reducing the hit to their pocketbooks.
Taking action on these two issues alone could have an immediate impact on improving outcomes for patients and reducing the hit to their pocketbooks.
NEW JERSEY DISPARITY STUDY #3
NEW JERSEY DISPARITY STUDY #4
Interested? Sign up!
The Northern Elite Workforce & Education program is dedicated to get the right people to the right places. For more information or to submit a proposal, contact us using the form below.
Now that government regulations have
both increased US prescription drug coverage rates to more than 93% and placed price caps on certain medications, it’s time to focus on other aspects of the healthcare system that adversely impact patients.
While the industry needs to both acknowledge that drug prices are too high and do more to lower prescription drug prices, there are far more urgent matters — such as lowering insurance premiums and preventing hospital overbilling — that will have an immediate effect on reducing costs and improving patient outcomes